The University of Chicago Header Logo

Connection

John Hart to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications John Hart has written about Adenocarcinoma.
John Hart
Connection Strength
2.486
Adenocarcinoma
  1. Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas. Hum Pathol. 2020 03; 97:103-111.
    View in: PubMed
    Score: 0.378
  2. Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma. Virchows Arch. 2020 Mar; 476(3):383-390.
    View in: PubMed
    Score: 0.371
  3. Measuring the Submucosal Depth of Invasion in Endoscopic Mucosal Resections for Barrett-associated Adenocarcinoma: Practical Issues and Relevance for the Decision for Esophagectomy. Arch Pathol Lab Med. 2022 11 01; 146(11):1338-1344.
    View in: PubMed
    Score: 0.116
  4. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer. 2002 Oct 01; 101(4):301-10.
    View in: PubMed
    Score: 0.115
  5. Endoscopic submucosal dissection for colorectal lesions: outcomes from a United States experience. Surg Endosc. 2022 01; 36(1):236-243.
    View in: PubMed
    Score: 0.103
  6. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
    View in: PubMed
    Score: 0.101
  7. Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility. Virchows Arch. 2021 Mar; 478(3):427-434.
    View in: PubMed
    Score: 0.100
  8. Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis. 2000 Jul; 21(7):1313-7.
    View in: PubMed
    Score: 0.098
  9. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Hum Pathol. 2019 07; 89:44-50.
    View in: PubMed
    Score: 0.091
  10. Colorectal Carcinomas With Isolated Loss of PMS2 Staining by Immunohistochemistry. Arch Pathol Lab Med. 2018 Apr; 142(4):523-528.
    View in: PubMed
    Score: 0.083
  11. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc. 2018 May; 87(5):1304-1309.
    View in: PubMed
    Score: 0.083
  12. Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. Inflamm Bowel Dis. 2016 Mar; 22(3):631-7.
    View in: PubMed
    Score: 0.073
  13. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016 Jul; 84(1):87-95.e1.
    View in: PubMed
    Score: 0.072
  14. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013 Dec; 45(12):1006-13.
    View in: PubMed
    Score: 0.062
  15. Development of subsquamous cancer after hybrid endoscopic therapy for intramucosal Barrett's cancer. Endoscopy. 2012; 44 Suppl 2 UCTN:E390-1.
    View in: PubMed
    Score: 0.058
  16. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46.
    View in: PubMed
    Score: 0.056
  17. Upregulation of glycogen synthase kinase 3ß in human colorectal adenocarcinomas correlates with accumulation of CTNNB1. Clin Colorectal Cancer. 2011 Mar 01; 10(1):30-6.
    View in: PubMed
    Score: 0.052
  18. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. 2010 Aug; 16(8):1352-6.
    View in: PubMed
    Score: 0.050
  19. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
    View in: PubMed
    Score: 0.046
  20. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64.
    View in: PubMed
    Score: 0.041
  21. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007 Dec; 39(12):1086-91.
    View in: PubMed
    Score: 0.040
  22. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res. 2007 Oct; 142(2):239-45.
    View in: PubMed
    Score: 0.040
  23. Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin? Surgery. 2005 Oct; 138(4):658-63; discussion 663-4.
    View in: PubMed
    Score: 0.035
  24. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 2005 Apr 15; 65(8):3146-54.
    View in: PubMed
    Score: 0.034
  25. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol. 2002 Jan; 97(1):27-31.
    View in: PubMed
    Score: 0.027
  26. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001 Nov; 25(11):1380-7.
    View in: PubMed
    Score: 0.027
  27. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
    View in: PubMed
    Score: 0.024
  28. A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase. Carcinogenesis. 2019 11 25; 40(11):1376-1386.
    View in: PubMed
    Score: 0.024
  29. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 01; 8(1):37-48.
    View in: PubMed
    Score: 0.020
  30. Ploidy as a prognostic feature in colonic adenocarcinoma. Arch Surg. 1996 Jun; 131(6):587-92.
    View in: PubMed
    Score: 0.019
  31. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer. 1994 Dec 01; 74(11):2908-17.
    View in: PubMed
    Score: 0.017
  32. Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. Surgery. 1994 Oct; 116(4):804-9; discussion 809-10.
    View in: PubMed
    Score: 0.017
  33. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am J Clin Pathol. 2005 Jul; 124(1):11-9.
    View in: PubMed
    Score: 0.009
  34. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol. 2000 Jun; 31(6):672-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.